Hypothermia for Increased Intracranial Pressure: Is It Dead?
Related Experiment Video
Updated: Mar 17, 2026

Short-Duration Hypothermia Induction in Rats using Models for Studies examining Clinical Relevance and Mechanisms
Published on: March 3, 2021
Christos Lazaridis1,2, Claudia S Robertson3
1Departments of Neurology, Baylor College of Medicine, McNair Campus 7200 Cambridge St., 9th Floor, MS: NB302, Houston, TX, 77030, USA. lazaridi@bcm.edu.
Abstract:
Mild to moderate therapeutic hypothermia (HT) has been used to alleviate intracranial hypertension in traumatic brain injury (TBI). Its main contribution is thought to be via reduction in cerebral metabolic requirement leading both to favorable oxygen/metabolic delivery-demand ratios as well as a reduction of cerebral blood volume resulting in decreased ICP. Nevertheless, HT is a clinically complex, labor-intensive procedure with numerous potential adverse effects. Furthermore, randomized controlled trials suggest either no effect or harm. These facts challenge the role of HT in TBI. We address this challenge by posing three questions that relate to the overarching value of controlling ICP, the effectiveness of HT in reducing ICP, and the benefit-risk ratio of the intervention. We conclude that HT should not be used as an "early" intervention unless as a part of a clinical trial, although it may still have a role in patients with refractory intracranial hypertension.
Related Concept Videos
Decreased Body Temperature
Increased Body Temperature
Methods of reducing fever
Pharmacological Methods of Reducing Fever:
Homeostatic Imbalances in Body Temperature
Requirements for Human Life
Oxygen
Atmospheric air is only about 20 percent oxygen, but that oxygen is a key component of the chemical reactions that keep the body alive, including the reactions that produce ATP. Brain cells are susceptible to a lack of oxygen because they require a...
Thermoregulation

